Insys Therapeutics Inc Banner Image

Insys Therapeutics Inc

  • Ticker INSY
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Insys Therapeutics Inc Logo Image
  • 201-500 Employees
  • Based in Chandler, Arizona
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a proprietary sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients; and Dronabinol SG Capsule, a dronabinol soft gelatin capsule that is generic equivalent to Marinol, an approved second-line treatment for chemotherapy-inducedMore nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. Its products candidates also include Dronabinol Oral Solution, a proprietary orally administered liquid formulation of dronabinol.
4.7 / 5.0 (183)

Insys Therapeutics Inc reports have an aggregate usefulness score of 4.7 based on 183 reviews.

Insys Therapeutics Inc

Most Recent Annual Report

Insys Therapeutics Inc
MOST RECENT 2018 Annual Report and Form 10K

Insys Therapeutics Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Insys Therapeutics Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!